A Study of LP-300 With Carboplatin and Pemetrexed in Never Smokers With Advanced Lung Adenocarcinoma | ClinicalTrials HQ

Ask about research services

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
A Study of LP-300 With Carboplatin and Pemetrexed in Never Smokers With Advanced Lung Adenocarcinoma	Neoplasms by Histologic Type, Neoplasms by Site, Thoracic Neoplasms, adenocarcinoma, bronchial neoplasm, bronchogenic carcinoma, carcinoma, epithelial neoplasm, lung adenocarcinoma, lung disorder, lung neoplasm, neoplasm, non-small cell lung carcinoma, respiratory system disorder, respiratory tract neoplasm	Recruiting	Phase 2	2026-05-04		NCT05456256

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
Lantern Pharma Inc.	3

16 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
Cancer and Blood Specialists Clinic	Los Alamitos	United States	1
Chi Mei Medical Center	Tainan	Taiwan	6
Fox Chase Cancer Center	Philadelphia	United States	259
Hokkaido Cancer Center	Sapporo	Japan	2
Inova Fairfax Hospital	Fairfax	United States	5
Kanagawa Cancer Center Hospital	Yokohama	Japan	1
Los Angeles Cancer Network	Fountain Valley	United States	2
National Cancer Center Hospital	Chuo-ku	Japan	17
National Cheng Kung University Hospital	Tainan	Taiwan	53
National Taiwan University Hospital Hsin-Chu Branch	Hsinchu	Taiwan	11
Okayama University Hospital	Okayama	Japan	5
Precision NextGen Oncology and Research Center	Beverly Hills	United States	5
Taipei Veterans General Hospital	Taipei	Taiwan	64
Tohoku University Hospital	Sendai	Japan	16
TriService General Hospital-Neihu Main Facility	Taipei	Taiwan	1
UT Southwestern Medical Center	Dallas	United States	27